Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozanimod Phase IV single-arm study in Chinese relapsing multiple sclerosis
CTR20240208Phase 4Active
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozanimod in multiple sclerosis (MS), sponsored by Bristol Myers Squibb. Started Jun 2024; status: active.
02
Drugs
ozanimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on CTR20240208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240208.